Commission grants Union authorisation to CID LINES active chlorine biocidal product family
Implementing Regulation (EU) 2026/2300 authorises the 'Active chlorine based products BPF' family held by CID LINES NV under the Biocidal Products Regulation.
The European Commission has adopted Implementing Regulation (EU) 2026/2300, dated 15 October 2026, granting a Union authorisation for the biocidal product family 'Active chlorine based products BPF'. The authorisation holder is CID LINES NV.
The measure was adopted under Regulation (EU) No 528/2012, the Biocidal Products Regulation. The act was published on EUR-Lex on 28 October 2026.
By way of context, a Union authorisation under this Regulation allows a biocidal product or product family to be made available across the EU, rather than being approved country by country.
The full text of the regulation was not available for this report. Details such as the authorisation dates, the specific product types and the conditions of use are therefore not covered here and should be checked in the published act.
The item concerns biocides, not medicinal products, so it has no direct bearing on pharmacovigilance or medicines regulation.
What it means for your team
- No direct impact on marketing authorisations or pharmacovigilance obligations, as this is a biocides measure.
- Quality assurance teams at sites that use chlorine-based disinfectants may wish to check the full regulation for the authorised uses and conditions.
- Anyone relying on CID LINES products should confirm the authorisation terms in the official EUR-Lex text before drawing conclusions.
Article written by VigiEye from the official source (EUR-Lex). AI-assisted; check the source before acting.